08048036315
Leading exporter of Genuine LIRAFIT Pen Injection  from India to Singapore - Tampines | Phoenix Exim

1. General Information

Lirafit Solution for Injection is an injectable antidiabetic medicine containing liraglutide 6 mg/mL. It belongs to the GLP-1 receptor agonist class and is used to help control elevated blood glucose in people with type 2 diabetes. It is generally administered by subcutaneous injection according to a healthcare professional's prescription.

2. Product Information

  • Brand: Lirafit
  • Active ingredient: Liraglutide
  • Strength: 6 mg/mL
  • Dosage form: Solution for injection
  • Pack: Commonly supplied as a 3 mL prefilled pen
  • Therapeutic class: Antidiabetic
  • Drug class: GLP-1 receptor agonist
  • Manufacturer/Marketer: Glenmark Pharmaceuticals Ltd
  • Storage: Refrigerate at 2–8°C; do not freeze.

3. Uses of Lirafit

Lirafit is primarily used for:

  • Management of type 2 diabetes mellitus
  • Improving blood-glucose control alongside appropriate diet and physical activity
  • Supporting better glycemic control when prescribed as part of an overall diabetes-treatment plan
  • It may also contribute to reduced appetite and weight reduction in some patients.

4. Benefits of Lirafit

When appropriately prescribed, liraglutide may:

  • Help lower elevated blood glucose
  • Increase glucose-dependent insulin release
  • Reduce appetite and food intake
  • Slow gastric emptying
  • Support weight reduction in some patients
  • Help improve overall glycemic control when combined with lifestyle measures.

Important: Benefits vary between individuals, and Lirafit should not be promoted as a general-purpose weight-loss injection without appropriate medical assessment.

5. Side Effects

Like other medicines, Lirafit can cause side effects. Gastrointestinal effects are particularly common.

Possible side effects include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Constipation
  • Decreased appetite
  • Indigestion
  • Abdominal discomfort or pain

More serious problems can occur less commonly, including pancreatitis, dehydration, gallbladder problems, or hypoglycemia, particularly when liraglutide is combined with insulin or sulfonylureas. Seek medical attention for severe or persistent abdominal pain, repeated vomiting, or symptoms of significant low blood sugar.

6. Common Side Effects

The commonly reported side effects include:

  1. Nausea
  2. Diarrhea
  3. Vomiting
  4. Reduced appetite
  5. Indigestion
  6. Constipation
  7. Abdominal discomfort

These effects may be more noticeable when treatment is started or the dose is increased.

7. How to Use Lirafit

Lirafit should be used only according to the prescribing healthcare professional's instructions.

  • It is generally administered under the skin (subcutaneously).
  • Common injection sites include the abdomen or thigh.
  • It should not be injected into a vein or muscle.
  • It can generally be administered with or without food.
  • Use it at approximately the same time each day when instructed.
  • A doctor or nurse should demonstrate the correct pen/injection technique before self-administration.
  • Do not change the dose or discontinue treatment without medical advice.

8. How Lirafit Works

Liraglutide is a GLP-1 receptor agonist. It mimics the action of the naturally occurring GLP-1 hormone.

It helps control blood sugar by:

  • Stimulating insulin release when blood glucose is elevated
  • Reducing inappropriate glucagon release
  • Slowing stomach emptying
  • Increasing feelings of fullness and reducing appetite

Together, these effects can help improve blood-glucose control and may contribute to weight reduction in some patients.

9. Safety Advice

  • Use only with a valid prescription and medical supervision.
  • Tell your doctor about any history of pancreatitis, gallbladder disease, severe gastrointestinal problems, or dehydration.
  • Inform your doctor about all diabetes medicines you take, particularly insulin or sulfonylureas, because the risk of hypoglycemia may increase.
  • Discuss use during pregnancy or breastfeeding with your healthcare professional.
  • Keep the medicine refrigerated at 2–8°C and do not freeze it.
  • Do not use the product if the solution appears abnormal or the packaging/pen is damaged.
  • Keep out of reach of children.
  • Because Lirafit is temperature-sensitive, appropriate cold-chain handling is important during pharmaceutical transportation.

10. FAQs

Q1. What is Lirafit used for?
Lirafit is primarily used to improve blood-glucose control in people with type 2 diabetes.

Q2. What is the active ingredient in Lirafit?
The active ingredient is liraglutide 6 mg/mL.

Q3. Is Lirafit an insulin injection?
No. Lirafit contains liraglutide and belongs to the GLP-1 receptor agonist class; it is not insulin.

Q4. How is Lirafit administered?
It is administered by subcutaneous injection according to a doctor's instructions.

Q5. Does Lirafit help with weight loss?
Liraglutide can reduce appetite and may contribute to weight loss in some patients, but its use should follow an appropriate medical indication and professional guidance.

Q6. How should Lirafit be stored?
It should generally be stored refrigerated at 2–8°C and must not be frozen.

Q7. Can I change the Lirafit dose myself?
No. Dose selection and adjustment should be determined by a qualified healthcare professional.

Q8. Is Lirafit prescription medicine?
Yes. Indian pharmacy references list Lirafit as a prescription medicine.

11. Substitute for Lirafit

Potential liraglutide-based alternatives may include products such as:

  • Victoza (liraglutide)
  • Other locally approved liraglutide products

Indian medicine references also list products such as Erly Prefilled Pen, Gliptoza Pre-filled Pen, and Lyrato Solution for Injection as substitutes/alternatives for Lirafit.

Important: A substitute should not be selected solely on the basis of brand or price. The active ingredient, strength, indication, formulation, and patient's medical condition should be reviewed by a healthcare professional.

12. SEO & B2B Keywords

For Phoenix Exim – pharmaceutical exporter from Nagpur, India, suitable keywords include:

  • Lirafit Solution for Injection exporter from India
  • Lirafit 6 mg/mL injection supplier
  • Lirafit injection pharmaceutical exporter
  • Liraglutide 6 mg/mL injection exporter India
  • Liraglutide injection supplier from Nagpur
  • Lirafit prefilled pen wholesale supplier
  • Lirafit injection bulk supplier India
  • Lirafit diabetes injection exporter
  • Liraglutide injection wholesale India
  • Lirafit 6 mg/mL pharmaceutical supplier
  • Lirafit injection international supplier
  • Liraglutide GLP-1 injection exporter
  • Lirafit medicine exporter Nagpur
  • Lirafit injection supplier UK
  • Lirafit injection supplier USA
  • Lirafit injection supplier Australia
  • Lirafit injection supplier Singapore
  • Lirafit injection supplier Canada
  • Lirafit injection supplier South Korea
  • Lirafit injection supplier UAE
  • Liraglutide diabetes medicine exporter India
  • GLP-1 receptor agonist supplier India
  • Type 2 diabetes injection supplier India
  • Liraglutide pharmaceutical export company
  • Lirafit solution for injection wholesale exporter
Aug 19th, 2026 2:54 PM

Keywords